INTRODUCTION
The T-cell activation gene 3 (TCA3) is a member of the β-chemokine family [1] , which is uniquely expressed in T-lymphocytes and mast cells, but not in B-lymphocytes, monocytes\macrophages or fibroblasts [2] . This gene was originally isolated from a murine T-cell clone by subtractive hybridization on the basis of its activation-specific message accumulation profile [3] . TCA3 is induced in CD4j and CD8j T-cell clones after antigen or mitogen stimulation [2] , and both Th1-and Th2-type cells express TCA3. TCA3 message is induced in murine mast cells after stimulation with PMA and the ionophore A23187, or after aggregation of the high-affinity IgE receptor (Fc ε RI) [4] . The structure of TCA3 consists of three exons and is similar to the structures of the MIP-1 genes [5] . Recombinant TCA3 causes neutrophil and macrophage chemotaxis in i o [1, 6] . TCA3 protein or TCA3-transfected Chinese hamster ovary cells when injected into mice with myeloma tumours induce complete tumour regression [7] . The human homologue of murine TCA3 is believed to be I-309 [8] , which has been shown to cause monocyte chemotaxis in itro [9] . Regulation of the expression of TCA3 has been extensively examined in mast cells following aggregation of Fc ε RI. Northern-blot analysis has demonstrated that TCA3 message appeared in mast cells within 2 h of mast cell activation, with a t "/# of 30 min. Nuclear run-on experiments have revealed that the induction of TCA3 message
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struct independent of cell activation. Electrophoretic mobility shift assays showed DNA-protein complex formation with subsequences (CCCCCATTCT) of NRE-1 (NRE-1a) and (CCATGA) of NRE-2 (NRE-2b). NRE-1a appears to be novel. NRE-2b is identical with a putative silencer motif in the α IIb integrin gene. Site-directed mutagenesis demonstrated that both NRE-1a and NRE-2b are important in the negative regulation of TCA3 promoter activity. In i o ligation-mediated PCR footprinting of the NRE-2 region revealed protection between k1372 and k1354, which contains NRE-2b. The data thus demonstrate identity of a silencer motif, here termed NRE-2b, in both the α IIb integrin gene and the TCA3, and that this silencer region in mast cells is functional both in i o and in itro. Further, evidence is presented that the promoter for TCA3 contains a novel silencer motif, termed NRE-1a, characterized by a CT-rich sequence.
is largely due to an increase in the level of transcription de no o [10] . Analysis of the promoter region has demonstrated that inducible gene expression is directed by a region extending k82 nt from the transcription start site, and that expression is enhanced by a region extending further to k1342. Electrophoretic mobility shift assays (EMSAs) revealed that protein in activated mast cells binds to a nuclear factor (NF)-κB element of TCA3. In these studies a putative inhibitory element was demonstrated between k2057 and k1342. While there is information about negative regulatory elements (NREs) controlling the expression of genes including interleukin (IL)-4 [11, 12] , the IL-2 receptor [13] and integrins [14] , nothing is known about the NREs controlling the expression of chemokines. Limitation of the expression of certain chemokines and thus the influx of specific inflammatory cells would be one mechanism by which an inflammatory response could be modified. This led us to further define the putative suppressor region of the promoter of TCA3. In order to verify the negative regulatory activity of the k2057 to k1342 region, a series of constructs with TCA3 and CD20 promoters containing NREs were generated. Following comparative sequence analysis, EMSAs were performed, which revealed specific DNA-protein complex formation in the regions k2002 to k1983, containing a NRE designated NRE-1a, and k1377 to k1348, containing a NRE termed NRE-2b. In i o footprinting and site-directed mutagenesis confirmed that both NRE-1a and NRE-2b are necessary for the negative regulatory activity between k2057 and k1342. As will be shown, NRE-2b is identical with the putative silencer motif of the α IIb integrin gene and NRE-1a appears to be novel.
MATERIALS AND METHODS

Cells
The cloned mast-cell line Cl.MC\C57.1 (provided by S. Galli, Harvard Medical School, Boston, MA, U.S.A.) was maintained as described [15] . Briefly, cells were cultured in Dulbecco's modified essential medium (DMEM) containing 10 % heatinactivated fetal-calf serum, 50 mM β-mercaptoethanol, 4 mM -glutamine and 100 mg\ml penicillin\streptomycin (complete DMEM) in a humidified 5 % CO # incubator. The cell number was adjusted to 5i10& cells\ml twice weekly by adding fresh media.
Stimulation conditions
For activation, mast cells were adjusted to a density of 1i10' cells\ml in complete DMEM and PMA (stock solution 1 mg\ml in DMSO) added at 50 ng\ml and A23187 (stock solution 10 mM in DMSO) added at 0.5 mM. Next the cells were incubated at 37 mC for 3 h in a humidified atmosphere of 5 % CO # \95 % air. Cells were then centrifuged at 400 g at 4 mC for 10 min and the cell pellet was resuspended in complete DMEM. The reaction was terminated by centrifugation at 400 g at 4 mC and the cells were washed twice by addition of ice-cold PBS.
Chloramphenicol acetyltransferase (CAT) reporter gene constructs
pE1bCAT (provided by D. Margolis, University of Massachusetts, Worcester, MA, U.S.A.) is a 4-kb pSP72 derivative carrying the CAT gene and E1b TATA box. Serial deletions of the 5h-end of the 2 kb CAT construct were made using the Erase-a-Base system (Promega, Madison, WI, U.S.A.). To generate an NRE-1-or NRE-2-TCA3-CAT construct, a promoter region encompassing the k2057 to k1493 region or the k1492 to k1342 region upstream from the transcription start site of TCA3 genomic DNA was isolated and inserted into the 5h-end (HindIII site) of a 0.7 kb or a 0.3 kb TCA3-CAT construct. To generate NRE-1-or NRE-2-CD20-CAT constructs, these NRE-1 or NRE-2 fragments were inserted into the HindIII site, immediately upstream of the human CD20 promoter (provided by J. Kehrl, NIH, Bethesda, MD, U.S.A.). Clones with 3h to 5h orientations were made for each NRE-TCA3-CAT construct or each NRE-CD20-CAT construct as internal controls. None of the TCA3-CAT constructs had an E1b TATA box.
Nucleotide sequence analysis
To verify the sequence and orientation of each CAT construct, DNA sequence analysis was performed using a Sequenase Version 2.0 kit (United States Biochemical, Cleveland, OH, U.S.A.) [16] . The DNA sequence was obtained by directed sequencing of inserts in the pSP72 vector with primers flanking the SP6 and T7 promoter regions to determine both strands.
Transfection and CAT assay
Transient transfection and CAT assays were performed as described with minor modifications [10] .
EMSA
EMSAs were performed as described [17, 18] to analyse binding of nuclear factors to both NRE-1 and NRE-2 sites. Doublestranded oligonucleotides were synthesized and labelled with [γ-$#P]ATP using the T4 polynucleotide kinase (Promega). Radiolabelled probe was incubated with 1 or 5 mg of nuclear extracts of either unstimulated mast cells or cells stimulated for 3 h with PMA and A23187. For competition assays, unlabelled specific oligonucleotides were used. For non-competitive assays, unlabelled unrelated oligonucleotides were employed. Nondenaturing PAGE (4 %, w\v) was performed at 100 V for 3 h using a desk-top electrophoresis apparatus, vertical slab gel unit SE 600 (Hoeffer Scientific Instruments, San Francisco, CA, U.S.A.), and the gel was dried and exposed for autoradiography.
In vivo methylation of cells and isolation of genomic DNAs
Cells, (50-100)i10', were methylated in i o as described [19, 20] . Subsequently, genomic DNAs were isolated directly from in i o methylated and control cells by suspending them in lysis buffer [10 mM Tris\HCl, pH 8.0\100 mM NaCl\25 mM EDTA\0.5 % (v\v) SDS\300 µg of proteinase K per ml] followed by incubation at 55 mC overnight with gentle agitation. DNAs were extracted by a standard method [21] . In itro methylation and subsequent cleavage of naked DNA with piperidine were carried out as described [22] . A trace amount of piperidine remaining in DNA preparations was removed by freeze-drying in a Speed-Vac (Savant) and by chromatography with a Sephadex G-50 spin column.
In vivo ligation-mediated (LM)-PCR footprinting
LM-PCR footprinting was performed as described with modification [23] . Exponential amplification was 3 min at 95 mC and 20 cycles with 1 min at 95 mC, 2 min at 63 mC and 3 min at 76 mC. The labelling cycle was 3 min at 95 mC and 2 cycles each for 1 min at 95 mC, 2 min at 66 mC and 10 min at 76 mC. For each footprinting experiment, a parallel cyclic PCR sequencing reaction was performed using a Sequitherm cycle sequencing kit with 1 pmol of an end-labelled primer 3. The sequencing method was employed as per the manufacturer's recommended procedures (Epicenter Technologies, Madison, WI, U.S.A.).
Oligonucleotide primers
For top-strand LM-PCR genomic footprinting analysis, specific primer sets were used for the initial extension reaction (primer 1), the exponential amplification reaction (primer 2) and the labelling reaction (primer 3). Primer sets for the top strand of NRE-2 were : primer 1 GGTTGTGCAGCCAGATAAAAACAG ; primer 2 TATGCAGTGGGCAGTACTTGGGATAAGC ; primer 3 AGCTCATAGGAGGCCCTCAAGAAAAAGCAG.
Site-directed mutagenesis
Site-directed mutagenesis was performed using the unique site elimination mutagenesis kit (Pharmacia Biotech, Uppsala, Sweden) according to the manufacturer's instructions. Briefly, a target mutagenic primer and a selection primer were annealed to both NRE-1-and NRE-2-0.7 kb TCA3-CAT constructs. The selection primer was generated by converting an A i II site into a BclI site in the amp gene carried in the NRE-TCA3-CAT construct. Plasmids with this primer still retained β-lactamase activity and displayed ampicillin resistance. Wild-type NRE-TCA3-CAT constructs, which still contained the A i II site, were linearized by restriction enzyme digestion with A i II. This reduced their ability to transform Escherichia coli. A repairdefective (mutS) strain of E. coli was transformed with NRE-TCA3-CAT constructs from the mutagenesis reaction. The plasmid DNA from transformed E. coli cells was used to transform competent E. coli DH5α cells following a second round of A i II selection. The mutated positive transformants were confirmed by sequencing analysis.
RESULTS
Evaluation of the 5h flanking sequence of TCA3 for negative regulatory activity
We have previously reported that the region between k2 kb and k1.3 kb contains negative regulatory activity [10] . To characterize this 5h-flanking sequence, this region was divided into two fragments, NRE-1 (k2057 to k1493) and NRE-2 (k1492 to k1342) on the basis of HindIII sites. These fragments were inserted into two fully functioning k728 and k324 TCA3-promoter-CAT constructs. Both NRE-1 and NRE-2 inhibited CAT-protein synthesis of both k728 and k324 TCA3-CAT constructs in the 5h-3h orientation ( Figure 1 ). NRE-1, but not NRE-2, was able to inhibit CAT-protein synthesis of both k728 and k324 TCA3-CAT constructs when placed in the 3h-5h orientation. Both NRE-1 and NRE-2 were thus distance (from
Figure 1 Schematic diagram of the TCA3 promoter constructs with or without NREs and CAT protein levels (pg/100 µg of total cellular protein) expressed in mast cells stimulated with PMA and A23187
A series of constructs containing the sequences encompassing k2057 to k1493 (NRE-1) or k1492 to k1342 (NRE-2) were joined to the fully functioning TCA3 promoter constructs k728 and k324 TCA3-CAT (constructs 1 and 6 in order from top to bottom) in both orientations (constructs 2, 3, 4, 5, 7, 8, 9 and 10). The 5h-deletion mutations, k2014 to k1342 (construct 13) and k1798 to k1342 (construct 14), were generated using 2 kb TCA3-CAT (construct 12) ; 1.3 kb TCA3-CAT was used as a positive control (construct 11) (see the Materials and methods section). The construct base numbering parallels the position of the upstream region of TCA3 with respect to the upstream sequence from the transcription start site. Suppression of reporter gene expression NRE-TCA3-CAT constructs is determined in mast cells stimulated with PMA and A23187, where equimolar amounts of TCA3-CAT constructs were used for transfection. Induction of reporter gene expression of NRE-CAT constructs in unstimulated mast cells was not detected (results not shown). Data are the average from one experiment performed in duplicate. Similar data were obtained in two additional experiments. Abbreviation used : mcg, µg.
transcription start site)-independent, but only NRE-1 was orientation-independent.
Determination of the minimal sequence between k2057 and k1493 required the inhibition of the promoter activity of TCA3 in mast cells. Progressive deletions of the 5h-flanking region of TCA3 were next generated and sequenced, and the transcriptional activity of the genomic DNA segment was assessed by CAT assay (Figure 1, constructs 13 and 14) . The 5h-deletion construct, k2014 to k1342, retained the negative regulatory activity of NRE-1. Further deletion of the 5h-end of the 2 kb CAT construct, k1798 to k1342, resulted in a loss of inhibitory activity of NRE-1. These results are consistent with the conclusion that the core motif for NRE-1 is located between k2014 and -1798.
Sequence analysis of the 5h-flanking region containing negative regulatory activity
To further investigate the transcriptional regulation of TCA3, we next sequenced the region encompassing k2057 to k1342 (Genbank accession number is U77972). Comparison of this sequence against published silencer motifs known to bind to
Table 1 Comparison of TCA3 NRE sequences with known/putative silencer motifs
The numbering parallels the position of the 5h-end of the deletion with respect to the upstream sequence from the transcription start site. Lower-case characters indicate unmatched bases.
Silencer 5h-end base Sequence
transcription factors resulted in the identification of sequences that are similar to or identical with the silencer motifs associated with IL-4 [11] , lysozyme [21] and α IIb integrin [14] ( Table 1 ). The 5h upstream region in NRE-1 contained the subsequence 5h-CCCCCATTCT-3h (k1998 to k1989) (NRE-1a) and the subsequence 5h-CTTCCCTCCT-3h (k1970 to k1961) (NRE-1b), both of which show similarities to the silencer motif of IL-4, 5h-CTCCCTTCT-3h [11] . A region in NRE-2 between k1379 and k1370 was found to have the sequence 5h-AACCCACTGT-3h (NRE-2a), that shows similarity to the silencer motif of lysozyme, 5h-ANCCCTCTCY-3h [24] . A region in NRE-2 between k1361 and k1356 contains 5h-CCATGA-3h (NRE-2b), which is identical with a putative silencer region in the α IIb integrin gene [14] .
Evaluation of promoter specificity of TCA3-NREs
To examine the promoter specificity of TCA3-NRE, and to determine whether these NREs have an inhibitory effect on gene expression in both resting and activated mast cells, we analysed the effect of NRE-1 and NRE-2 on the expression of the CAT reporter gene in a CD20-CAT construct containing a human CD20 promoter (Figure 2 ). The CD20 promoter contains at least
Figure 2 Schematic diagram of the CD20-CAT promoter constructs with or without NREs and their CAT protein levels (pg/100 µg of total cellular protein) in unstimulated mast cells and mast cells stimulated with PMA and A23187
A series of constructs containing the TCA3 upstream sequences encompassing k2057 to k1493 (NRE-1) or k1492 to k1342 (NRE-2) were joined to fully functioning CD20 promoter constructs. two positive regulatory elements. These are Oct-1 and Oct-2 [25] . NF-κB is not known to regulate the transcription of CD20 gene. We have reported that TCA3-CAT constructs show undetectable levels of transcription in resting mast cells regardless of the presence of the NRE region [10] . In contrast, the CD20 promoter-CAT construct has relatively high transcriptional activity in resting cells (Figure 3) . Further, both NRE-1 and NRE-2 in either orientation down-regulated the promoter activity of CD20-CAT in both resting and activated mast cells. Both NRE-1 and NRE-2, when used individually, were capable of inhibiting greater than 85 % of the promoter activity, suggesting the negative regulatory region of TCA3 has a redundancy of NREs for expression of CAT from the CD20 promoter in resting cells. Neither NRE was able to direct CAT-protein synthesis when inserted into the HindIII site immediately upstream of the cytomegalovirus (CMV) promoter in a CMV-CAT construct (results not shown). These results indicate that the activity of NRE-1 and NRE-2 is not specific to the TCA3 promoter, and that the effects of NRE-1 and NRE-2 on at least one promoter (the CD20 promoter) is independent of induction.
Identification of the silencer motif of NRE-1 using EMSA
In order to examine the putative silencer regions identified by functional analysis using CAT assays, EMSAs were performed next. Oligonucleotides containing NRE-1a, NRE-1b and the silencer motif of IL-4 were generated ( Figure 3 ). EMSA using NRE-1a and NRE-1b revealed that nuclear proteins from both resting ( Figure 3 , lanes 2 and 5) and activated ( Figure 3 , lanes 3 and 6) cells were able to bind to oligonucleotide NRE-1a ( Figure  3 , lanes 2 and 3) but not to NRE-1b ( Figure 3 , lanes 5 and 6). A protein or protein complex binding to NRE-1a, here referred to as chemokine negative regulatory factor-1 (CNRF-1), was observed both in resting mast cells and in mast cells activated with PMA and A23187 ( Figure 3, lanes 2 and 3) . Thus we next characterized NRE-1a further but not NRE-1b, which did not show gel retardation.
To verify the specificity of this CNRF-1-NRE-1a complex, competition experiments were performed. Labelled oligonucleotide NRE-1a was incubated with nuclear extracts prepared from unstimulated mast cells ( Figure 3 , lanes 2-6) in the presence of specific or non-specific competitor oligonucleotides (Figure 3,  lanes 3-6) . The addition of excess unlabelled competitor containing NRE-1a (Figure 3, lane 3) , but not the competing oligonucleotides containing the silencer motif of the IL-4 gene (Figure 3, lane 4) , blocked the CNRF-1-NRE-1a complex. Formation of the complex was not blocked by competitor containing NRE-1b (Figure 3, lane 5) or an unrelated heterologous competitor (Figure 3, lane 6 ). These results demonstrate that the shift of oligonucleotide NRE-1a is not due to the protein interacting with the silencer motif of the IL-4 gene.
Identification of the silencer motifs of NRE-2 using EMSA
In order to characterize NRE-2 further, EMSAs were again performed. Overlapping oligonucleotides (A-F) encompassing NRE-2 were generated (Figure 4 
Comparative analysis of the silencer motifs of NRE-2 of TCA3 with EMSA
To determine the inducibility and specificity of the CNRF-2-oligonucleotide D and CNRF-3-oligonucleotide E complexes in the NRE-2 region, competitors were synthesized that contained NRE-2a with a short flanking sequence (20 bp, whereas oligonucleotide D has 40 bp), the silencer motif of lysozyme, NRE-2b with a short flanking sequence (20 bp, whereas oligonucleotide E has 40 bp), the silencer motif of α IIb integrin, deletion mutants of NRE-2b of TCA3, and the silencer motif of α IIb integrin ( Figure  5 ). To determine the specificity of the CNRF-2-oligonucleotide D interaction, labelled oligonucleotide D containing NRE-2a was incubated with nuclear extracts prepared from unstimulated ( as oligonucleotide A ( Figure 5, lane 9) . The observation that NRE-2a with a short flanking sequence, which oligonucleotide D contains, did not compete with oligonucleotide D indicates that NRE-2a, which is similar to the silencer motif of lysozyme, is not responsible for the gel retardation.
To determine the specificity of the CNRF-3-NRE-2b interaction, labelled oligonucleotide E containing NRE-2b was incubated with nuclear extracts prepared from unstimulated ( Figure 5, lanes 11 and 13-18 ) and stimulated ( Figure 5 , lane 12) mast cells in the presence of specific ( Figure 5, lane 13) or nonspecific competitor oligonucleotides ( Figure 5, lanes 14-18) . CNRF-3-NRE-2b complex formation did not require treatment of mast cells with PMA and A23187, as shown by the appearance of these complexes in both lanes 11 and 12 of Figure 5 . The specificity of this CNRF-3-NRE-2b complex was confirmed by competition experiments. Addition of excess unlabelled oligonucleotide E blocked this complex formation ( Figure 5, lane 13) . Addition of unlabelled competitors at 25-and 75-fold molar excess to either NRE-2b of TCA3 or the putative silencer motif of α IIb integrin ( Figure 5, lanes 14, 15 and 16, 17 ) blocked this complex formation in a dose-response manner. These results suggest that the shift of NRE-2b is due to CNRF-3, which also interacts with the silencer motif of α IIb integrin.
Site-directed mutagenesis of NRE-1a and NRE-2b
To confirm the functionality of the subsequences NRE-1a and NRE-2b, in down-regulating the promoter activity of TCA3, the activity of NRE-1a and NRE-2b was assessed in NRE-1-and NRE-2-0.7 kb TCA3-CAT constructs respectively. Five bases in either NRE-1a or NRE-2b in NRE-1-or NRE-2-TCA3-CAT constructs were mutated ( Figure 6A ). The activities of NRE-1-and NRE-2-0.7 kb TCA3-CAT construct with and without a mutation were assayed by measuring the CAT protein expression. The ∆NRE-1-0.7 kb TCA3-CAT construct had less than 20 % of the negative regulatory activity of NRE-1, indicating NRE-1a is essential for the negative regulatory activity of NRE-1. The ∆NRE-2-0.7 kb TCA3-CAT construct had approx. 65 % of the negative activity of NRE-2, suggesting that NRE-2b is necessary but not sufficient to confer the negative regulatory activity of NRE-2, consistent with the possibility that sequences neighbouring such as NRE-2a contained in oligonucleotide D are also involved in negative regulatory activity.
In vivo footprinting of the NRE-2 region of TCA3
To further characterize the extent of NRE-2b, we next identified the regions of direct protein-DNA contact by employing in i o LM-PCR footprinting after dimethyl sulphate (DMS) treatment on the NRE-2 region of TCA3. Oligonucleotides specific for the various upstream regions of TCA3 were used as described in the Materials and methods section. As shown in Figure 7 , the top strand of the TCA3 promoter region from position k1372 to k1354 encompassing NRE-2b is protected by protein(s) from both resting mast cells and mast cells stimulated with PMA and A23187. The footprinting gel shows reduced intensity of G and A residues with relatively hypersensitive GG residues (k1365 to k1364) with both in i o resting and stimulated cells. Thus these in i o data are in agreement with the data from EMSA showing a specific CNRF-3-NRE-2b interaction ( Figure 5 ) and sitedirected mutagenesis showing that NRE-2b is necessary for the negative regulatory activity of NRE-2 ( Figure 6 ).
DISCUSSION
We have previously demonstrated that transcription was undetectable by CAT assays when a 2 kb TCA3-CAT construct containing the region between k2057 and k1342 was transfected into mast cells [10] . However, induced transcription was restored upon deletion of this region from the 2 kb TCA3-CAT construct. In addition to the potential enhancer elements between k1341 and k136 within the 5h-flanking region of TCA3, these results strongly suggested the existence of silencer elements between k2057 and k1342. As reported in this paper, further analysis with multiple NRE constructs, including 5h-deletion mutants, revealed that multiple regions, rather than a single sequence element, contribute to NRE activity (Figure 1 ). Both NRE-1 and NRE-2 were able to inhibit approx. 60 % of CAT-protein synthesis of TCA3-CAT constructs, confirming the presence of distinct NREs between k2057 and k1342. This finding suggested that negative regulation of TCA3 involved multiple elements [26] , and co-operation of NRE-1 and NRE-2 was required for more efficient down-regulation of the TCA3 promoter.
Both NRE-1 and NRE-2 were distance (from transcription start site)-independent, but only NRE-1 was orientationindependent ( Figure 1 ). Silencers were initially defined as autonomous cis-acting NREs that function in a position-and orientation-independent manner [27] . However, silencers that are position-dependent [24, 28] or orientation-dependent [29, 30] have now been reported, which is consistent with the data on NRE-1 and NRE-2.
When either NRE-1 or NRE-2 was inserted into a CAT construct containing the CD20 promoter, the transcriptional The k201 to k181 region containing the NF-κB regulatory element has previously been shown to be occupied by NF-κB after activation. The k2002 to k1983, k1407 to k1383 and k1372 to k1354 regions are occupied by transcription factors independent of activation. activity conveyed by the promoter was substantially reduced (Figure 2 ). Like many other silencers, both NRE-1 and NRE-2 from TCA3 were able to inhibit the activity of a heterologous promoter [24, 29, [31] [32] [33] [34] [35] . Furthermore, both NRE-1 and NRE-2 alone inhibited more than 85 % of the promoter activity of CD20-CAT. These results indicate a redundancy of NREs within the TCA3 promoter. Such functional redundancy is observed in the regulatory elements of other genes, including enhancers, silencers and locus control regions [32] .
Both NRE-1a and NRE-1b subsequences in the NRE-1 region are similar to a portion of the IL-4 NRE [11] (Table 1, Figure 3) . However, NRE-1a only revealed specific DNA-protein complex formation, and this shift of NRE-1a was not due to the protein interacting with the silencer motif of the IL-4 gene ( Figure 3B ). Deletion of a region containing both NRE-1a and NRE-1b subsequences abolished the negative regulatory activity of NRE-1 (Figure 1 ). Site-directed mutagenesis experiments revealed that altering NRE-1a resulted in a significant loss of negative regulatory activity (Figure 1 ). These results suggest that NRE-1a represents a novel silencer region.
NRE-2a is similar to the silencer motif [24] ANCCCTCTCY, identified in cis-NREs of genes encoding human collagen type II [36] , and lysozyme [24] (Table 1) , as well as other genes including human ε-globulin [37] ACCCTCTTC. However, an unlabelled oligonucleotide containing NRE-2a with a short flanking sequence failed to inhibit the shift of oligonucleotide D ( Figure 5 ). These results suggest that while NRE-2a is not responsible for the gel retardation, oligonucleotide D may contain a yet to be characterized silencer sequence.
NRE-2b contains CCATGA, which is identical with one of the putative silencer motifs of the α IIb integrin gene (Table 1) , and exhibits reverse complementarity to the other putative silencer motif of the α IIb integrin gene, TGATGG. Competitors containing the CCATGA motif as seen in TCA3 and the silencer region of the α IIb integrin gene abolished specific DNA-protein complex formation ( Figure 5 ). Also LM-PCR footprinting in i o on the NRE-2 region revealed protection between k1372 and k1354, which contains the CCATGA motif ( Figure 7 ). These results suggest that both TCA3 and the α IIb integrin gene share the same silencer protein(s). The silencer motif of the α IIb integrin gene has been reported to correlate with the differentiation-dependent expression of this gene. Site-directed mutagenesis of the CCATGA motif resulted in the partial loss of the negative regulatory activity of NRE-2 ( Figure 6 ). These results are consistent with the conclusion that the CCATGA motif is necessary but not sufficient to confer the negative regulatory activity of NRE-2. Both EMSA and LM-PCR footprinting in i o also demonstrated the binding of a nuclear protein or protein complex to the NRE-2b region in both uninduced and induced mast cells. Although we were not able to correlate results from uninduced mast cells with the data from transient transfection experiments using TCA3 promoter constructs, due to undetectable levels of promoter activity in resting mast cells, we did examine the effect of NRE-1 and NRE-2 on CD20 in CD20-CAT. With this construct, CAT protein synthesis was detectable in resting mast cells (Figure 2 ). Inhibition of transcription occurred with NRE-1 or NRE-2 in both induced and uninduced mast cells. Thus both NRE-1a and NRE-2b may function as general rather than induction-specific regressors of TCA3 gene activity. The combined control by enhancer(s) and NREs would thus result in balanced TCA3 gene expression. We have shown that the transcription rate of TCA3 is undetectable in resting mast cells by Northern-blot analysis, nuclear run-on experiments and CAT assays using TCA3-CAT constructs with or without the NRE region. These results suggest that the repression of the basal transcription rate of TCA3 in the resting mast cells is not due to the action of NREs [11] . In contrast with the undetectable CAT protein synthesis by a 2 kb TCA3-CAT construct following mast cell activation, the mRNA level of the endogenous TCA3 gene was elevated [10] . This discrepancy may be due to complex DNA-protein and\or protein-protein interactions requiring additional elements in the upstream region from the NREs [11, 12, 38] , an intronic sequence [39] , or a 3h-untranslated region to overcome the negative regulatory activity [40] .
In summary, we have demonstrated functional NREs in TCA3 (Figure 8 ). This information adds to the understanding of the regulation of TCA3 that has been described as having a functional NF-κB binding site [10] . NRE-1 is distance-independent and orientation-independent ; NRE-2 is distanceindependent and orientation-dependent. Neither region is specific to TCA3. Both NRE-1 and NRE-2 function in mast cells independent of cell activation. NRE-1 contains NRE-1a, which binds to the hypothetical CNRF-1 ; NRE-2 contains NRE-2b, which binds to hypothetical CNRF-3, and a second binding region from k1407 to k1383, which binds to hypothetical CNRF-2 and requires further characterization. Both NRE-1a and NRE-2b participate in the transcriptional regulation of TCA3 gene expression along with enhancers in mast cells upon activation. The NREs may be important cis-acting regulators for other genes. Further characterization of nuclear factors binding to these elements and delineation of the 5h upstream region containing these NREs will provide further insight into the role of negative regulation in the expression of chemokines.
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